Stagnating sales and delayed rights issue adds to Zoono’s woes

Stagnating sales and delayed rights issue adds to Zoono’s woes
Zoono did it tough after covid induced boom. (Image: Getty)
Denise McNabb
A mounting stockpile of unsold product with looming expiry dates and the postponement of a non-renounceable rights issue due to undisclosed “external circumstances” are the latest woes for cash-strapped Australian securities exchange-listed New Zealand hand and sanitiser manufacturer Zoono Group.In its second quarterly report to December 2023, released Wednesday, the company acknowledged significant work needed to be done before it was cashflow positive and profitable.The group reported a $514,000 net cash deficit on operating activ...

More Markets

NZX down as property company gets key renewal
Markets Market Close

NZX down as property company gets key renewal

ASB Bank has extended the lease for its downtown Auckland site for another nine years.

Anna Scott joining Mercer
Markets

Anna Scott joining Mercer

Former Smart boss will replace current Mercer chief executive Martin Lewington.

Solar still on the rise, Ecotricity says
Markets

Solar still on the rise, Ecotricity says

Commercial solar generation is up almost 300%.

Expectations of rate cuts boost NZ sharemarket in light trade
Markets Market close

Expectations of rate cuts boost NZ sharemarket in light trade

There were 89 rises and 48 falls on the main board.

Jamie Gray 02 Jul 2025